DLG4 and early-onset autosomal dominant Alzheimer disease: We evaluated the treatment of Alzheimer’s disease with nasal inhalation delivery of WGA-NPs-miR132 through analysis of water maze experiments, Aβ, SYN, and PSD95 levels and apoptotic ratios, which were representative indicators of cognitive dysfunction.